Pharmicell Co. Ltd. | Ownership
Companies that own Pharmicell Co. Ltd.
The Vanguard Group, Inc.
1,226,963
2.04%
33,869
0%
07/31/2018
BlackRock Advisors (UK) Ltd.
130,449
0.22%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
113,619
0.19%
27,590
0.02%
04/30/2018
Dimensional Fund Advisors LP
85,904
0.14%
-111,808
0%
04/30/2018
SSgA Funds Management, Inc.
71,352
0.12%
0
0%
09/06/2018
Charles Schwab Investment Management, Inc.
67,829
0.11%
0
0%
09/06/2018
BlackRock Fund Advisors
21,103
0.04%
0
0%
09/05/2018
Samsung Asset Management Co., Ltd.
13,861
0.02%
8,934
0.01%
07/06/2018
Analytic Investors LLC
6,254
0.01%
6,254
0%
07/31/2018
State Street Global Advisors Ltd.
5,978
0.01%
0
0%
09/05/2018
| Address |
7/F, Sang-Bong Building
Seoul SL 06017
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.pharmicell.com |
| Updated |
07/08/2019 |
| Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. It operates through Bio and Chemical Business Divisions. The Bio division provides cosmetics, cell for researches, medical testing equipment, and others. |
